Skip to main content
UniHealth

Doctor search

Daniel Dongjune Shin, MD

Infectious Disease · Mountain View

NPI 1427065960

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
5
3 carriers
Offices
4

Offices

4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: 757662 · El Camino Health. That is not proof they admit you there this week.

Plans that list them

5 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

5 of 5 plans

Plans whose provider directory lists this clinician
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A72218 · Current

Licensed to practise in California · since 2000 · expires 2028-06-30 · Loyola University of Chicago Stritch School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$67,133

Medicare paid this office $67,133 for 226 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes127$31,722$106
Initial hospital care with moderate level of medical decision making at least 75 minutes76$11,965$153
Return visit (30+ min)42$7,504$109
Long return visit (40+ min)31$7,439$155
New patient visit (60+ min)23$4,512$196

Who their Medicare patients are

226 Original Medicare patients in 2024. Average age 77 · Under 65 8% · 85 and older 24% · Women 46% · Also on Medicaid 20% · Health risk score 2.45. At or below the middle of the specialty; the typical infectious disease clinician is at 3.

Conditions among them: High blood pressure 75% · Coronary heart disease 44% · Chronic kidney disease 39% · Atrial fibrillation 39% · Diabetes 38% · Heart failure 35% · COPD 32% · Depression 27% · Dementia 23% · Cancer 22% · Stroke 15%.

The office billed $243,819, Medicare allowed $86,655 and paid $67,133; for 554 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024226554772.45$243,819$67,133
2023228606772.45$264,623$75,791
2022201817762.85$301,569$84,741
2021230613762.65$241,938$71,520
2020237960752.89$283,209$93,213
2019240762752.89$267,154$75,951
2018206627752.88$212,481$62,913
2017198688752.83$223,473$66,913
2016195760742.49$231,647$69,639
2015197745742.51$220,563$71,976
2014218879742.55$263,181$79,024
2013195737732.49$228,536$66,996

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes131$37,110$110
Initial hospital care with moderate level of medical decision making at least 75 minutes85$14,953$161
Return visit (30+ min)50$9,510$115
Long return visit (40+ min)36$6,665$159
New patient visit (60+ min)31$5,974$193

2022: 6 services

Original Medicare services billed in 2022
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes122$45,495$97
Initial hospital care with moderate level of medical decision making at least 75 minutes80$16,246$185
Return visit (30+ min)49$10,455$110
New patient visit (60+ min)22$4,489$204
Long return visit (40+ min)20$3,681$147
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes18$1,345$67

2021: 7 services

Original Medicare services billed in 2021
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes112$25,817$100
Initial hospital care with moderate level of medical decision making at least 75 minutes108$20,801$187
Return visit (30+ min)43$8,808$111
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes55$5,662$69
New patient visit (60+ min)17$3,421$201
Long return visit (40+ min)16$3,056$153
Short return visit (20+ min)11$992$76

2020: 5 services

Original Medicare services billed in 2020
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes105$36,288$101
Initial hospital care with moderate level of medical decision making at least 75 minutes116$25,065$199
Return visit (30+ min)49$10,001$99
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes82$9,957$72
New patient visit (60+ min)21$4,025$192

2019: 7 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes119$28,678$95
Initial hospital care with moderate level of medical decision making at least 75 minutes102$19,213$178
Return visit (30+ min)61$9,811$96
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes75$8,151$64
New patient visit (60+ min)23$4,011$174
Long return visit (40+ min)16$2,227$106
Hospital discharge day management, 30 minutes or less12$724$60

2018: 7 services

Original Medicare services billed in 2018
Initial hospital care with moderate level of medical decision making at least 75 minutes79$15,754$179
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes46$13,177$93
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes87$11,109$64
Return visit (30+ min)62$11,078$93
Long return visit (40+ min)29$4,904$123
New patient visit (60+ min)18$3,158$175
Short return visit (20+ min)12$971$61

2017: 6 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes100$17,683$64
Initial hospital care with moderate level of medical decision making at least 75 minutes82$14,863$179
Return visit (30+ min)52$10,632$93
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes32$8,787$92
Long return visit (40+ min)38$8,531$127
New patient visit (60+ min)19$3,615$190

2016: 7 services

Original Medicare services billed in 2016
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes105$21,152$64
Initial hospital care with moderate level of medical decision making at least 75 minutes80$14,939$178
Return visit (30+ min)49$9,401$96
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$8,557$92
Long return visit (40+ min)33$7,489$121
New patient visit (60+ min)22$4,006$182
Short return visit (20+ min)15$1,270$67

2015: 6 services

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes129$24,652$68
Initial hospital care with moderate level of medical decision making at least 75 minutes80$16,065$189
Return visit (30+ min)51$12,291$102
Long return visit (40+ min)29$6,636$130
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$6,340$98
New patient visit (60+ min)13$2,435$187

2014: 7 services

Original Medicare services billed in 2014
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes140$28,871$64
Initial hospital care with moderate level of medical decision making at least 75 minutes92$17,990$180
Return visit (30+ min)49$10,102$95
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes38$9,151$92
Long return visit (40+ min)32$5,770$128
New patient visit (60+ min)14$2,638$188
Short return visit (20+ min)17$1,430$65

2013: 7 services

Original Medicare services billed in 2013
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes101$18,956$62
Initial hospital care with moderate level of medical decision making at least 75 minutes82$15,670$174
Return visit (30+ min)63$11,943$93
Long return visit (40+ min)24$5,068$118
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes26$4,760$90
New patient visit (60+ min)22$3,952$180
Short return visit (20+ min)18$1,764$63

Medicaid work

$906 in 2023

Medicaid paid $906 for 35 billed services this clinician did in 2023, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES35$906
Medicaid work by year
202335113$906
202198115$10,282
202024114$472
201944213$1,538
201853214$1,189
See the largest Medicaid services in earlier years

2021

Largest Medicaid services in 2021
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES98$10,282

2020

Largest Medicaid services in 2020
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES24$472

2019

Largest Medicaid services in 2019
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES32$1,100
Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter12$438

2018

Largest Medicaid services in 2018
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES39$919
Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter14$271

Drugs they prescribed that Part D paid

$773,570

Pharmacies billed $773,570 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

490 generic and 203 brand-name prescriptions · $773,570 in drug cost · 266 antibiotic prescriptions to 73 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
BiktarvyNone63$271,204$4,305
DescovyNone41$102,740$2,506
GammakedImmune globulin12$93,186$7,766
TivicayNone22$60,530$2,751
JulucaNone13$52,992$4,076
See all 24 drugs
Every Part D drug this clinician prescribed
BiktarvyNone63$271,204$4,305
DescovyNone41$102,740$2,506
GammakedImmune globulin12$93,186$7,766
TivicayNone22$60,530$2,751
JulucaNone13$52,992$4,076
IsentressNone13$29,596$2,277
MaravirocNone13$13,283$1,022
RifabutinNone20$8,209$410
PosaconazoleNone17$6,486$382
VancomycinNone21$5,176$246
ErtapenemNone14$3,337$238
FluconazoleNone17$1,308$77
EthambutolNone30$1,299$43
Lamivudine HbvNone11$558$51
Amoxicillin-Clavulanate PotassNone18$440$24
CefazolinNone11$423$38
Sulfamethoxazole-TrimethoprimNone25$390$16
LevofloxacinNone34$384$11
CeftriaxoneNone20$354$18
Doxycycline HyclateNone16$310$19
AzithromycinNone19$221$12
CephalexinNone18$156$9
MirtazapineNone14$100$7
MetforminNone15$31$2

Year by year

Part D prescribing by year
2024693107None29%$773,570
2023604104NoneNone$504,878
202257390NoneNone$388,734
202153185None20%$235,313
202054779None12%$271,954
201942772NoneNone$135,993
201843984None18%$171,684
201746170None14%$176,505
2016606675% (27)12%$134,239
2015523656% (32)10%$120,055
2014458634% (19)16%$133,937
2013447616% (28)19%$111,710

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 22 drugs

Part D drugs prescribed in 2023
BiktarvyNone39$183,860$4,714
GammakedImmune globulin12$88,467$7,372
JulucaNone13$47,013$3,616
DescovyNone19$44,766$2,356
TivicayNone15$33,298$2,220
IsentressNone12$25,683$2,140
MaravirocNone12$15,878$1,323
FluconazoleNone18$3,864$215
RifampinNone29$3,829$132
AbacavirNone11$3,746$341
VancomycinNone18$2,892$161
AzithromycinNone26$2,632$101
EthambutolNone33$1,439$44
Sulfamethoxazole-TrimethoprimNone22$771$35
CeftriaxoneNone29$731$25
Ampicillin-SulbactamNone15$721$48
CefazolinNone18$698$39
Lamivudine HbvNone12$631$53
Doxycycline HyclateNone15$563$38
LevofloxacinNone15$379$25
MirtazapineNone12$130$11
IsoniazidNone21$125$6

2022: 13 drugs

Part D drugs prescribed in 2022
Biktarvy24$88,593$3,691
Descovy23$51,126$2,223
Moxifloxacin13$6,023$463
Fluconazole26$4,718$181
Cefepime19$4,668$246
Ceftriaxone41$3,877$95
Rifampin35$2,851$81
Vancomycin16$2,725$170
Azithromycin32$2,591$81
Ethambutol49$1,975$40
Doxycycline Hyclate11$549$50
Amoxicillin-Clavulanate Potass12$402$33
Sulfamethoxazole-Trimethoprim19$321$17

2021: 13 drugs

Part D drugs prescribed in 2021
Biktarvy21$72,395$3,447
Rifampin42$4,481$107
Fluconazole23$4,195$182
Micafungin13$2,461$189
Fosfomycin Tromethamine12$2,425$202
Meropenem13$1,745$134
Minocycline15$1,681$112
Clindamycin24$1,244$52
Ampicillin14$1,123$80
Ethambutol35$1,012$29
Azithromycin37$646$17
Cefazolin11$569$52
Sulfamethoxazole-Trimethoprim15$393$26

2020: 17 drugs

Part D drugs prescribed in 2020
Biktarvy25$82,777$3,311
Daptomycin16$51,469$3,217
Cefepime18$12,330$685
Ceftriaxone19$5,737$302
Fluconazole37$5,400$146
Rifampin45$4,197$93
Minocycline36$3,379$94
Ampicillin-Sulbactam29$3,350$116
Vancomycin13$2,032$156
Ethambutol34$1,265$37
Sulfamethoxazole-Trimethoprim14$1,177$84
Doxycycline Hyclate21$1,094$52
Clindamycin15$1,059$71
Azithromycin21$907$43
Ondansetron Odt15$478$32
Cephalexin11$120$11
Isoniazid12$87$7

2019: 11 drugs

Part D drugs prescribed in 2019
Biktarvy21$66,521$3,168
Rifampin54$4,196$78
Fluconazole22$3,995$182
Ampicillin-Sulbactam30$2,920$97
Minocycline36$2,669$74
Doxycycline Hyclate18$1,641$91
Clindamycin11$813$74
Azithromycin11$800$73
Amoxicillin-Clavulanate Potass12$417$35
Sulfamethoxazole-Trimethoprim16$293$18
Isoniazid12$69$6

2018: 11 drugs

Part D drugs prescribed in 2018
Vancomycin12$3,715$310
Rifampin34$3,493$103
Fluconazole16$3,004$188
Ethambutol30$2,384$79
Doxycycline Hyclate11$1,764$160
Meropenem14$1,754$125
Azithromycin22$1,238$56
Amoxicillin-Clavulanate Potass16$903$56
Ceftriaxone17$889$52
Cefazolin11$701$64
Isoniazid12$70$6

2017: 13 drugs

Part D drugs prescribed in 2017
Atripla14$36,449$2,603
Ampicillin-Sulbactam22$5,575$253
Rifampin46$3,765$82
Ethambutol42$2,896$69
Ampicillin24$2,563$107
Azithromycin34$1,397$41
Ceftriaxone22$1,080$49
Doxycycline Hyclate11$475$43
Amoxicillin-Clavulanate Potass11$461$42
Prednisone17$208$12
Sodium Chloride13$204$16
Isoniazid13$76$6
Furosemide11$24$2

2016: 20 drugs

Part D drugs prescribed in 2016
Atripla11$31,219$2,838
Colcrys13$5,236$403
Fluconazole13$2,988$230
Rifampin40$2,792$70
Ethambutol42$2,342$56
Morphine Sulfate Er11$1,585$144
Azithromycin22$1,411$64
Levofloxacin15$1,409$94
Amoxicillin-Clavulanate Potass32$1,304$41
Moxifloxacin11$1,028$93
Dapsone13$863$66
Mirtazapine20$702$35
Doxycycline Hyclate11$280$25
Prednisone20$253$13
Sulfamethoxazole-Trimethoprim15$219$15
Isoniazid17$118$7
Alendronate13$91$7
Amoxicillin11$75$7
Amlodipine Besylate11$67$6
Furosemide18$23$1

2015: 17 drugs

Part D drugs prescribed in 2015
Vancomycin30$10,645$355
Rifabutin12$8,696$725
Colcrys12$4,241$353
Ampicillin13$3,503$269
Ceftriaxone19$3,461$182
Rifampin33$3,001$91
Ethambutol31$2,447$79
Moxifloxacin15$1,531$102
Amoxicillin-Clavulanate Potass31$1,224$39
Clarithromycin12$1,018$85
Azithromycin17$972$57
Morphine Sulfate Er11$675$61
Hydromorphone11$453$41
Pantoprazole13$349$27
Prednisone25$276$11
Sulfamethoxazole-Trimethoprim18$129$7
Isoniazid14$106$8

2014: 12 drugs

Part D drugs prescribed in 2014
Cubicin17$42,062$2,474
Rifampin27$4,303$159
Vancomycin14$3,229$231
Ethambutol35$3,095$88
Ampicillin18$3,034$169
Ceftriaxone13$3,007$231
Azithromycin18$1,558$87
Clarithromycin11$1,155$105
Ciprofloxacin15$650$43
Amox Tr-Potassium Clavulanate16$460$29
Sulfamethoxazole-Trimethoprim15$189$13
Isoniazid25$150$6

2013: 12 drugs

Part D drugs prescribed in 2013
Piperacillin-Tazobactam34$9,361$275
Epivir Hbv12$4,987$416
Rifampin12$1,865$155
Ethambutol11$1,321$120
Azithromycin18$1,166$65
Vancomycin11$967$88
Amox Tr-Potassium Clavulanate13$692$53
Sulfamethoxazole-Trimethoprim30$511$17
Minocycline24$400$17
Sodium Chloride25$391$16
Fluconazole12$381$32
Acyclovir21$328$16

Money from drug and device companies

$12 in 2025

Industry payments by year
202511None$12
202211None$26

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Gilead SciencesNone$12
1 payment
  • Education · 2025-11-18 · $12
See the published payment
Every published payment
Gilead SciencesEducation · 2025-11-18None$12
See earlier years (2022)

2022: $26

Payments by company in 2022
AmgenLumakras$26
1 payment
  • Meals for Lumakras · 2022-10-17 · $26

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Gilead Sciences, Inc. · The Simple Study - Subjects With Mild To Moderate Coronavirus Infection · 2020Their institution$39,249
Gilead Sciences, Inc. · The Simple Study - Subjects With Mild To Moderate Coronavirus Infection · 2021Their institution$21,864
Gilead Sciences, Inc. · A Phase 1b/2a Study in A Phase 1b/2a Study in Participants With Early Stage Covid-19 To Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered By Inhalation · 2021Their institution$19,949
Gilead Sciences, Inc. · The Simple Study in Coronavirus, Severe Subjects · 2021Their institution$19,744
Gilead Sciences, Inc. · The Simple Study in Coronavirus, Severe Subjects · 2020Their institution$9,261

Professional record

NPI
1427065960
Licence
CA A72218California A72218: Current · expires 2028-06-30
Trained
Loyola University of Chicago, Stritch School of Medicine, 1995
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RI0200X (207RI0200X)
Mailing address
2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
NPI first listed
2006-08-01
NPI last updated
2012-01-06

This is when the NPI record was last certified, not a medical board exam.